Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 87501-87550 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04833790
What Drives Poor Care for Child Diarrhea: A Standardized Patient Experiment
NA
Active, not recruiting
2,451 participants
Started: May 5, 2022 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05548712
The Effect of PEMF for Patients With Knee OA
NA
Recruiting
80 participants
Started: May 5, 2022 · Completed: Sep 15, 2024
2 conditions
1 sponsor
1 location
NCT05337137
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
PHASE1/PHASE2
Active, not recruiting
162 participants
Started: May 5, 2022 · Completed: Nov 7, 2025
1 condition
1 sponsor
61 locations
NCT05741814
Propofol Sedation vs. Anaesthetist Guided Anaesthesia in Oocyte Pickup
NA
Recruiting
100 participants
Started: May 5, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04644289
WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC
PHASE2
Recruiting
60 participants
Started: May 5, 2022 · Completed: Jun 30, 2028
1 condition
1 sponsor
6 locations
NCT05040360
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
PHASE2
Recruiting
141 participants
Started: May 5, 2022 · Completed: Mar 31, 2027
5 conditions
2 sponsors
319 locations
NCT04732416
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
PHASE2
Recruiting
16 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
7 locations
NCT05354323
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
PHASE1
Active, not recruiting
6 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT05775029
RSI Observation Follow-up
N/A
Active, not recruiting
2,300 participants
Started: May 5, 2022 · Completed: Jun 1, 2025
4 conditions
1 sponsor
2 locations
NCT06724471
Preservation of Women's Fertility: Evaluation of Innovative Methods for Ovarian Tissue Cryopreservation
N/A
Active, not recruiting
30 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05225363
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
PHASE1
Recruiting
33 participants
Started: May 5, 2022 · Completed: Jun 5, 2027
1 condition
2 sponsors
1 location
NCT05395325
Clinical Effects of Combined Kinesiotaping and Steroid Injection in Stroke Patients With Hemiplegic Shoulder Pain
NA
Recruiting
50 participants
Started: May 5, 2022 · Completed: Aug 31, 2024
2 conditions
1 sponsor
1 location
NCT05416879
Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure
N/A
Recruiting
40 participants
Started: May 5, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05371626
Cicatricial Upper Eyelid Entropion Management
NA
Recruiting
30 participants
Started: May 5, 2022 · Completed: Jun 1, 2024
1 condition
1 sponsor
1 location
NCT05369845
Observance of Continuous Positive Pressure for the Treatment of Obstructive Sleep Apnea Syndrome
NA
Active, not recruiting
132 participants
Started: May 5, 2022 · Completed: Jun 30, 2026
4 conditions
1 sponsor
1 location
NCT05171049
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
PHASE3
Active, not recruiting
1,150 participants
Started: May 5, 2022 · Completed: Feb 28, 2027
3 conditions
2 sponsors
209 locations
NCT04976036
Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
PHASE2
Recruiting
48 participants
Started: May 5, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT05339932
Grand Valley State University (GVSU) Skills on Wheels
NA
Active, not recruiting
4 participants
Started: May 5, 2022 · Completed: Dec 31, 2027
6 conditions
1 sponsor
1 location
NCT05550246
Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
PHASE1/PHASE2
Recruiting
22 participants
Started: May 5, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05267041
Joint Thoracic Oncology Research Unit of LYon: Lung CancerS DatabaSE (ULYSSE)
NA
Recruiting
4,000 participants
Started: May 5, 2022 · Completed: May 5, 2042
1 condition
1 sponsor
1 location
NCT06160479
The Incidence of Hypocalcemia in Pregnant Women at Siriraj Hospital
NA
Active, not recruiting
444 participants
Started: May 5, 2022 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT05221359
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
NA
Recruiting
8 participants
Started: May 5, 2022 · Completed: Apr 30, 2027
2 conditions
1 sponsor
1 location
NCT05349331
Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma
PHASE2
Active, not recruiting
74 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05090891
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
PHASE2
Recruiting
98 participants
Started: May 5, 2022 · Completed: Dec 23, 2032
1 condition
1 sponsor
27 locations
NCT05151120
Harmonization of Thyroid-stimulating Hormone Immunoassays Reagents
N/A
Recruiting
100 participants
Started: May 5, 2022 · Completed: May 5, 2026
2 conditions
1 sponsor
2 locations
NCT05017935
RADIANCE Continued Access Protocol
NA
Active, not recruiting
300 participants
Started: May 4, 2022 · Completed: Dec 31, 2028
4 conditions
1 sponsor
40 locations
NCT05078164
Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy
NA
Recruiting
300 participants
Started: May 4, 2022 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT05431361
PRehab tO PreparE Living Liver Donors for Enhanced Recovery
NA
Active, not recruiting
30 participants
Started: May 4, 2022 · Completed: Dec 12, 2024
1 condition
1 sponsor
1 location
NCT05973981
The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment
NA
Recruiting
900 participants
Started: May 4, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05140434
Evaluation of the Benefit of Exercise Testing for the Diagnosis of Obstruction in the Coronary Arteries of the Heart
N/A
Recruiting
120 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06128148
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
PHASE1
Recruiting
101 participants
Started: May 4, 2022 · Completed: Dec 30, 2027
4 conditions
1 sponsor
1 location
NCT05103436
Electrical Stimulation for Spasticity in Spinal Cord Injury
NA
Active, not recruiting
40 participants
Started: May 4, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05807256
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
N/A
Recruiting
500 participants
Started: May 4, 2022 · Completed: Nov 30, 2025
5 conditions
1 sponsor
1 location
NCT05347771
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
PHASE2
Recruiting
240 participants
Started: May 4, 2022 · Completed: Dec 15, 2025
1 condition
4 sponsors
8 locations
NCT05371964
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
PHASE1
Recruiting
51 participants
Started: May 4, 2022 · Completed: Aug 31, 2028
1 condition
1 sponsor
8 locations
NCT05365672
Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
PHASE2
Recruiting
126 participants
Started: May 4, 2022 · Completed: Dec 31, 2028
1 condition
2 sponsors
8 locations
NCT05085171
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
PHASE3
Recruiting
2,400 participants
Started: May 4, 2022 · Completed: Sep 1, 2027
1 condition
2 sponsors
1 location
NCT05344703
Is Y-Balance Test Predictive of Concussion
NA
Recruiting
1,000 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
2 locations
NCT05179876
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
PHASE3
Recruiting
280 participants
Started: May 4, 2022 · Completed: Sep 28, 2029
1 condition
1 sponsor
40 locations
NCT05272631
Depuy Synthes Lower Extremity Shaft Nail Registry
N/A
Active, not recruiting
250 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
8 locations
NCT05356182
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
NA
Recruiting
30 participants
Started: May 4, 2022 · Completed: Feb 28, 2027
3 conditions
1 sponsor
1 location
NCT05167695
Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention
NA
Active, not recruiting
160 participants
Started: May 4, 2022 · Completed: Jul 1, 2026
1 condition
1 sponsor
1 location
NCT05514028
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
N/A
Recruiting
250 participants
Started: May 4, 2022 · Completed: Apr 30, 2026
3 conditions
3 sponsors
12 locations
NCT05285566
Pain Control for Undergoing Costal Cartilage Harvesting
PHASE4
Recruiting
60 participants
Started: May 4, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05183490
R-MVST Cells for Treatment of Viral Infections
PHASE1
Recruiting
36 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT04904302
Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer
PHASE2
Active, not recruiting
88 participants
Started: May 3, 2022 · Completed: Jan 31, 2027
3 conditions
1 sponsor
2 locations
NCT05269004
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
PHASE3
Active, not recruiting
1,300 participants
Started: May 3, 2022 · Completed: Dec 31, 2029
1 condition
1 sponsor
235 locations
NCT05398276
Behavioral Exposure for Introceptive Tolerance RCT
PHASE2
Recruiting
146 participants
Started: May 3, 2022 · Completed: Jul 31, 2026
4 conditions
2 sponsors
2 locations
NCT05280548
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
PHASE3
Active, not recruiting
104 participants
Started: May 3, 2022 · Completed: Dec 6, 2027
1 condition
1 sponsor
54 locations
NCT05159856
Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes
N/A
Recruiting
400 participants
Started: May 3, 2022 · Completed: Dec 31, 2025
5 conditions
2 sponsors
1 location
Previous
1
More pages
1748
1749
1750
1751
1752
1753
1754
More pages
2369
Next